{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:05:36Z","timestamp":1791993936804,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.ymgme.2020.04.006","type":"journal-article","created":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T19:08:19Z","timestamp":1588532899000},"page":"209-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["A comprehensive testing algorithm for the diagnosis of Fabry disease in males and females"],"prefix":"10.1016","volume":"130","author":[{"given":"Ashlee R.","family":"Stiles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"McCaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Beasley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Rehder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwight D.","family":"Koeberl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deeksha S.","family":"Bali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah P.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ymgme.2020.04.006_bb0005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pharmthera.2009.01.003","article-title":"Fabry disease","volume":"122","author":"Schiffmann","year":"2009","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.ymgme.2020.04.006_bb0010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/cge.12613","article-title":"X-chromosome inactivation in female patients with Fabry disease","volume":"89","author":"Echevarria","year":"2016","journal-title":"Clin. Genet."},{"issue":"2","key":"10.1016\/j.ymgme.2020.04.006_bb0015","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.gene.2012.06.013","article-title":"X-inactivation in Fabry disease","volume":"505","author":"Elstein","year":"2012","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.ymgme.2020.04.006_bb0020","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.12914","article-title":"Time delays in the diagnosis and treatment of Fabry disease","volume":"71","author":"Reisin","year":"2017","journal-title":"Int. J. Clin. Pract."},{"issue":"26","key":"10.1016\/j.ymgme.2020.04.006_bb0025","first-page":"440","article-title":"Fabry disease-often seen, rarely diagnosed","volume":"106","author":"Hoffmann","year":"2009","journal-title":"Deutsches Arzteblatt Int."},{"issue":"5","key":"10.1016\/j.ymgme.2020.04.006_bb0030","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1053\/j.ajkd.2010.10.046","article-title":"Urinary total globotriaosylceramide and isoforms to identify women with Fabry disease: a diagnostic test study","volume":"57","author":"Paschke","year":"2011","journal-title":"Am. J. Kidney Dis."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2020.04.006_bb0035","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cccn.2004.10.019","article-title":"Screening for Fabry disease using whole blood spots fails to identify one-third of female carriers","volume":"353","author":"Linthorst","year":"2005","journal-title":"Clin. Chim. Acta"},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2020.04.006_bb0040","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0009-8981(01)00478-8","article-title":"Fabry disease: enzymatic diagnosis in dried blood spots on filter paper","volume":"308","author":"Chamoles","year":"2001","journal-title":"Clin. Chim. Acta"},{"issue":"4 Supplement","key":"10.1016\/j.ymgme.2020.04.006_bb0045","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.jpeds.2009.07.003","article-title":"Guidelines to diagnosis and monitoring of fabry disease and review of treatment experiences","volume":"155","author":"Martins","year":"2009","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.ymgme.2020.04.006_bb0050","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/cge.12449","article-title":"Diagnostic dilemmas in Fabry disease: a case series study on GLA mutations of unknown clinical significance","volume":"88","author":"Smid","year":"2015","journal-title":"Clin. Genet."},{"issue":"10","key":"10.1016\/j.ymgme.2020.04.006_bb0055","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jacc.2016.06.026","article-title":"Challenges in the diagnosis of Anderson-Fabry disease: a deceptively simple and yet complicated genetic disease","volume":"68","author":"Marian","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ymgme.2020.04.006_bb0060","first-page":"101","article-title":"Questioning the pathogenic role of the GLA p.Ala143Thr \u201cmutation\u201d in Fabry disease: implications for screening studies and ERT","volume":"8","author":"Terryn","year":"2013","journal-title":"JIMD Rep."},{"issue":"2","key":"10.1016\/j.ymgme.2020.04.006_bb0065","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ymgme.2014.11.004","article-title":"The alpha-galactosidase A p.Arg118Cys variant does not cause a Fabry disease phenotype: data from individual patients and family studies","volume":"114","author":"Ferreira","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2020.04.006_bb0070","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF03402156","article-title":"Fabry disease: twenty novel alpha-galactosidase A mutations and genotype-phenotype correlations in classical and variant phenotypes","volume":"8","author":"Germain","year":"2002","journal-title":"Mol. Med."},{"issue":"2","key":"10.1016\/j.ymgme.2020.04.006_bb0075","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ijcard.2014.09.001","article-title":"Uncertain diagnosis of Fabry disease: consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significance","volume":"177","author":"Smid","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ymgme.2020.04.006_bb0080","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cca.2017.01.018","article-title":"Biomarkers associated with clinical manifestations in Fabry disease patients with a late-onset cardiac variant mutation","volume":"466","author":"Auray-Blais","year":"2017","journal-title":"Clin. Chim. Acta"},{"issue":"23\u201324","key":"10.1016\/j.ymgme.2020.04.006_bb0085","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.cca.2010.07.038","article-title":"How well does urinary lyso-Gb3 function as a biomarker in Fabry disease?","volume":"411","author":"Auray-Blais","year":"2010","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.ymgme.2020.04.006_bb0090","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2174\/0929867311320020008","article-title":"A metabolomic study reveals novel plasma lyso-Gb3 analogs as Fabry disease biomarkers","volume":"20","author":"Dupont","year":"2013","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"10.1016\/j.ymgme.2020.04.006_bb0095","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2215\/CJN.06090809","article-title":"Biomarkers of Fabry disease nephropathy","volume":"5","author":"Schiffmann","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ymgme.2020.04.006_bb0100","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/gim.2018.31","article-title":"Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysis","volume":"21","author":"Maruyama","year":"2018","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2020.04.006_bb0105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cca.2012.09.026","article-title":"LC-MS\/MS analysis of plasma lyso-Gb3 in Fabry disease","volume":"414","author":"Boutin","year":"2012","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2020.04.006_bb0110","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3733","article-title":"Alpha-galactosidase A deficiency: Fabry disease","author":"Desnick","year":"2001"},{"issue":"5","key":"10.1016\/j.ymgme.2020.04.006_bb0115","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2020.04.006_bb0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cca.2014.08.002","article-title":"Urinary biomarker investigation in children with Fabry disease using tandem mass spectrometry","volume":"438","author":"Auray-Blais","year":"2015","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.ymgme.2020.04.006_bb0125","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10545-011-9395-4","article-title":"Functional analysis of variant lysosomal acid glycosidases of Anderson-Fabry and Pompe disease in a human embryonic kidney epithelial cell line (HEK 293 T)","volume":"35","author":"Ebrahim","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"issue":"12","key":"10.1016\/j.ymgme.2020.04.006_bb0130","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/BF03401993","article-title":"Twenty novel mutations in the alpha-galactosidase A gene causing Fabry disease","volume":"5","author":"Topaloglu","year":"1999","journal-title":"Mol. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2020.04.006_bb0135","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/BF03401671","article-title":"Fabry disease: thirty-five mutations in the alpha-galactosidase A gene in patients with classic and variant phenotypes","volume":"3","author":"Eng","year":"1997","journal-title":"Mol. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2020.04.006_bb0140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/504601","article-title":"High incidence of later-onset fabry disease revealed by newborn screening","volume":"79","author":"Spada","year":"2006","journal-title":"Am. J. Hum. Genet."},{"issue":"9","key":"10.1016\/j.ymgme.2020.04.006_bb0145","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/jhg.2016.52","article-title":"Fabry disease in patients with hypertrophic cardiomyopathy: a practical approach to diagnosis","volume":"61","author":"Seo","year":"2016","journal-title":"J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.ymgme.2020.04.006_bb0150","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13023-016-0441-z","article-title":"Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant","volume":"11","author":"Lenders","year":"2016","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2020.04.006_bb0155","first-page":"1","article-title":"Renal globotriaosylceramide deposits for Fabry disease linked to uncertain pathogenicity gene variant c.352C>T\/p.Arg118Cys: a family study","volume":"7","author":"Ceron-Rodriguez","year":"2019","journal-title":"Mol. Genet. Genom. Med."},{"key":"10.1016\/j.ymgme.2020.04.006_bb0160","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.cca.2015.06.003","article-title":"Variations in the GLA gene correlate with globotriaosylceramide and globotriaosylsphingosine analog levels in urine and plasma","volume":"447","author":"Ferreira","year":"2015","journal-title":"Clin. Chim. Acta"},{"issue":"12","key":"10.1016\/j.ymgme.2020.04.006_bb0165","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.3390\/ijms19123726","article-title":"Mutations in the GLA gene and LysoGb3: is it really Anderson-Fabry disease?","volume":"19","author":"Duro","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ymgme.2020.04.006_bb0170","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","article-title":"Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy","volume":"138","author":"Desnick","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ymgme.2020.04.006_bb0175","doi-asserted-by":"crossref","first-page":"17002","DOI":"10.1038\/hgv.2017.2","article-title":"A new mutation found in newborn screening for Fabry disease evaluated by plasma globotriaosylsphingosine levels","volume":"4","author":"Chinen","year":"2017","journal-title":"Hum. Genom. Variation"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719220301128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719220301128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:25:50Z","timestamp":1761089150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719220301128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1096719220301128"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2020.04.006","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comprehensive testing algorithm for the diagnosis of Fabry disease in males and females","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2020.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}